11
H index
14
i10 index
535
Citations
University of Melbourne (47% share) | 11 H index 14 i10 index 535 Citations RESEARCH PRODUCTION: 59 Articles 8 Papers 4 Books RESEARCH ACTIVITY: 28 years (1994 - 2022). See details. MORE DETAILS IN: ABOUT THIS REPORT: Permalink: http://citec.repec.org/pde347 |
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin. | Is cited by: | Cites to: |
Journals with more than one article published | # docs |
---|---|
PharmacoEconomics | 15 |
The European Journal of Health Economics | 12 |
Health Policy | 6 |
Health Economics | 5 |
Applied Health Economics and Health Policy | 5 |
Medical Decision Making | 4 |
Social Science & Medicine | 4 |
PharmacoEconomics - Open | 2 |
The Patient: Patient-Centered Outcomes Research | 2 |
Working Papers Series with more than one paper published | # docs |
---|---|
Working Papers / Centre for Health Economics, University of York | 5 |
Monograph / Office of Health Economics | 4 |
Year | Title of citing document | |
---|---|---|
2024 | Whats in a Bill? A Model of Imperfect Moral Hazard in Healthcare. (2022). Zhu, ED ; Anderson, David M ; Hoagland, Alex. In: Papers. RePEc:arx:papers:2211.01116. Full description at Econpapers || Download paper | |
2023 | Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose. (2023). Manski, Charles F. In: Papers. RePEc:arx:papers:2305.17206. Full description at Econpapers || Download paper | |
2024 | Biases in the healthcare luxury good hypothesis?: a metaâ€regression analysis. (2011). Costa-i-Font, Joan ; Rubert, Gloria ; Gemmill, Marin ; CostaFont, Joan . In: Journal of the Royal Statistical Society Series A. RePEc:bla:jorssa:v:174:y:2011:i:1:p:95-107. Full description at Econpapers || Download paper | |
2023 | The use of patient-reported outcome and experience measures for health policy purposes: A scoping review in oncology. (2023). Ferrua, M ; Fourcade, A ; Fierobe, A ; Minvielle, E ; Mir, O ; Scotte, F ; di Palma, M. In: Health Policy. RePEc:eee:hepoli:v:129:y:2023:i:c:s0168851022003165. Full description at Econpapers || Download paper | |
2024 | Marginal cost per QALY estimates: What are they good for?. (2024). Cookson, Graham ; Sampson, Chris. In: Health Policy. RePEc:eee:hepoli:v:142:y:2024:i:c:s0168851024000460. Full description at Econpapers || Download paper | |
2023 | The functions of known to be inaccurate prices in markets: A cross-country comparison of pharmaceutical list pricing. (2023). Krafve, Linus Johansson ; Sjogren, Ebba ; Kjellberg, Hans. In: Journal of Business Research. RePEc:eee:jbrese:v:167:y:2023:i:c:s0148296323005520. Full description at Econpapers || Download paper | |
2024 | Competition, value-based prices and incentives to research personalised drugs. (2024). Levaggi, Rosella. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697. Full description at Econpapers || Download paper | |
2023 | Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review. (2023). Cutler, Henry ; Gu, Yuanyuan ; Seil, Elizabeth ; Bilgrami, Anam ; Jeet, Varinder ; Ahumada-Canale, Antonio. In: Social Science & Medicine. RePEc:eee:socmed:v:322:y:2023:i:c:s0277953623001478. Full description at Econpapers || Download paper | |
2023 | Randomised comparison of online interviews versus face-to-face interviews to value health states. (2023). Dalziel, Kim ; Yang, Yaling ; Rowen, Donna ; Devlin, Nancy ; Bourke, Mackenzie ; Peasgood, Tessa. In: Social Science & Medicine. RePEc:eee:socmed:v:323:y:2023:i:c:s0277953623001752. Full description at Econpapers || Download paper | |
2023 | Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs). (2023). Madan, Jason ; Stewart-Brown, Sarah ; Petrou, Stavros ; Buckell, John ; Edmund, Hei Hang. In: Social Science & Medicine. RePEc:eee:socmed:v:327:y:2023:i:c:s027795362300285x. Full description at Econpapers || Download paper | |
2023 | A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom. (2023). Kanavos, P ; Montibeller, G ; Angelis, A. In: Social Science & Medicine. RePEc:eee:socmed:v:337:y:2023:i:c:s0277953623005932. Full description at Econpapers || Download paper | |
2023 | “Its not a one operation fits all”: A qualitative study exploring fee setting and participation in price transparency initiatives amongst medical specialists in the Australian private healthcare secto. (2023). Mendez, Susan ; la Brooy, Camille ; Sabanovic, Hana ; Prang, Khic-Houy ; Elshaug, Adam G ; Scott, Anthony ; Yong, Jongsay. In: Social Science & Medicine. RePEc:eee:socmed:v:339:y:2023:i:c:s0277953623007104. Full description at Econpapers || Download paper | |
2024 | Understanding UK public views on normative decisions made to value health-related quality of life in children: A qualitative study. (2024). Keetharuth, Anju ; Rowen, Donna ; Powell, Philip A ; Mukuria, Clara. In: Social Science & Medicine. RePEc:eee:socmed:v:340:y:2024:i:c:s0277953623008638. Full description at Econpapers || Download paper | |
2024 | A happiness approach to valuing health states for children. (2024). Dalziel, Kim ; Chen, Gang ; Devlin, Nancy ; Huang, LI. In: Social Science & Medicine. RePEc:eee:socmed:v:348:y:2024:i:c:s0277953624002466. Full description at Econpapers || Download paper | |
2023 | Identifying the value of a clinical information system during the COVID-19 pandemic. (2023). Jones, Paul ; Madhavan, Naveen. In: Technovation. RePEc:eee:techno:v:120:y:2023:i:c:s0166497221002273. Full description at Econpapers || Download paper | |
2023 | Making an economic argument for investment in global mental health: the case of conflict-affected refugees and displaced people. (2023). Park, A-La ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:118149. Full description at Econpapers || Download paper | |
2023 | Open and inclusive: fair processes for financing universal health coverage. (2023). Kurowski, Christoph. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:119795. Full description at Econpapers || Download paper | |
2023 | . Full description at Econpapers || Download paper | |
2023 | . Full description at Econpapers || Download paper | |
2023 | . Full description at Econpapers || Download paper | |
2023 | . Full description at Econpapers || Download paper | |
2023 | . Full description at Econpapers || Download paper | |
2024 | . Full description at Econpapers || Download paper | |
2023 | National Quality and Sustainable Development: An Empirical Analysis Based on China’s Provincial Panel Data. (2023). Wang, Yu Kun ; Liu, Duochenxi ; You, Shibing. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:6:p:4879-:d:1092320. Full description at Econpapers || Download paper | |
2023 | Effect of price transparency on the perception of fair price and satisfaction with the purchase of sports products. (2023). Aghaei, Malihe Sadat ; Mirzazadeh, Zahra Sadat ; Sepehrian, Amir Hossein. In: Journal of Revenue and Pricing Management. RePEc:pal:jorapm:v:22:y:2023:i:5:d:10.1057_s41272-022-00391-w. Full description at Econpapers || Download paper | |
2024 | Health Expenditure and Economic Growth Nexus: Empirical Evidence from South Asian Countries. (2024). Das, Aurolipsa ; Mohanty, Saileja ; Sethi, Narayan ; Sahoo, Malayaranjan. In: Global Business Review. RePEc:sae:globus:v:25:y:2024:i:2_suppl:p:s229-s243. Full description at Econpapers || Download paper | |
2024 | Testing Nonmonotonicity in Health Preferences. (2024). Sanchez Martinez, Fernando Ignacio ; Sanchez-Martinez, Fernando-Ignacio ; Abellan-Perpian, Jose-Maria ; Martinez-Perez, Jorge-Eduardo ; Pinto-Prades, Jose-Luis. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:1:p:42-52. Full description at Econpapers || Download paper | |
2023 | Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7. Full description at Econpapers || Download paper | |
2023 | Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. (2023). Attema, Arthur ; Shah, Koonal K ; Zhang, Liying ; Lipman, Stefan A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01466-6. Full description at Econpapers || Download paper | |
2023 | A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program. (2023). Luo, Nan ; Tan, Rachel Lee-Yin ; Chong, Sheue-Lih ; Wang, Pei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01479-1. Full description at Econpapers || Download paper | |
2023 | Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study. (2023). Rand, Kim ; Stavem, Knut ; Hansen, Tonya Moen. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01517-y. Full description at Econpapers || Download paper | |
2023 | Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. (2023). Blizzard, Leigh C ; Palmer, Andrew J ; Carroll, William M ; Butzkueven, Helmut ; Simpson-Yap, Steve ; Kalincik, Tomas ; Mason, Deborah F ; Norman, Richard ; Taylor, Bruce V ; Campbell, Julie A ; Henson, Glen J ; Claflin, Suzi ; van der Mei, Ingrid. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01518-x. Full description at Econpapers || Download 2023 | Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0. Full description at Econpapers || Download paper |
2023 | What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains. (2023). Jakubczyk, Micha. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01537-8. Full description at Econpapers || Download paper | |
2023 | To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study. (2023). Dongen, Johanna M ; Ben, Angela Jornada ; Bosmans, Judith E ; el Alili, Mohamed ; Finch, Aureliano Paolo. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01539-6. Full description at Econpapers || Download paper | |
2023 | Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. (2023). Arrow, Peter ; Hettiarachchi, Ruvini M ; Kularatna, Sanjeewa ; Jamieson, Lisa ; Tonmukayawul, Utsana ; Norman, Richard ; Brain, David ; Carter, Hannah ; Senanayake, Sameera. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01542-x. Full description at Econpapers || Download 2023 | Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs). (2023). Mukuria, Clara ; Caruana, Julia M ; Peasgood, Tessa. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:3:d:10.1007_s40271-022-00611-w. Full description at Econpapers || Download paper |
2023 | Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Children’s Involvement and Qualitative Methods. (2023). Carlton, Jill ; Gale, Victoria. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:5:d:10.1007_s40271-023-00637-8. Full description at Econpapers || Download paper | |
2023 | Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia. (2023). Lloyd, Andrew ; Freitas, Hayley ; Aggio, Daniel ; Kruger, Eliza. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00397-z. Full description at Econpapers || Download paper | |
2023 | Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. (2023). Rutherford, Carolyn ; Kirchmann, Matt ; Zibelnik, Natasa ; Wayi-Wayi, Grace ; Ademi, Zanfina ; Abrams, Keith R ; Shupo, Francis ; Makarounas-Kirchmann, Kelly. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:5:d:10.1007_s41669-023-00426-x. Full description at Econpapers || Download paper | |
2023 | What are Valid Weights for the Human Development Index? A Discrete Choice Experiment for the United Kingdom. (2023). Feeny, Simon ; Ombler, Franz ; Knowles, Stephen ; Hansen, Paul ; McGillivray, Mark. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:165:y:2023:i:2:d:10.1007_s11205-022-03039-9. Full description at Econpapers || Download paper | |
2023 | The effects of price transparency and debt collection policies on intentions to consume recommended health care: A randomized vignette experiment. (2023). Ko, Hansoo ; Epstein, Wendy Netter ; Robertson, Christopher T. In: Journal of Empirical Legal Studies. RePEc:wly:empleg:v:20:y:2023:i:4:p:941-960. Full description at Econpapers || Download paper |
Year | Title | Type | Cited |
---|---|---|---|
1995 | Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform. [Full Text][Citation analysis] | article | 0 |
1994 | The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health. [Citation analysis] | article | 0 |
2000 | The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers. [Full Text][Citation analysis] | paper | 6 |
2011 | Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers. [Full Text][Citation analysis] | paper | 5 |
2012 | Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2013 | Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers. [Full Text][Citation analysis] | paper | 49 |
2013 | The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers. [Full Text][Citation analysis] | paper | 8 |
2015 | Local health care expenditure plans and their opportunity costs In: Health Policy. [Full Text][Citation analysis] | article | 4 |
2020 | Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy. [Full Text][Citation analysis] | article | 1 |
2020 | The impact of price transparency on consumers and providers: A scoping review In: Health Policy. [Full Text][Citation analysis] | article | 6 |
1996 | The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy. [Full Text][Citation analysis] | article | 8 |
2006 | Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy. [Full Text][Citation analysis] | article | 7 |
2009 | Searching for cost effectiveness thresholds in the NHS In: Health Policy. [Full Text][Citation analysis] | article | 27 |
2020 | A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine. [Full Text][Citation analysis] | article | 6 |
1999 | The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine. [Full Text][Citation analysis] | article | 3 |
2005 | Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine. [Full Text][Citation analysis] | article | 9 |
2009 | A note on the nature of utility in time and health and implications for cost utility analysis In: Social Science & Medicine. [Full Text][Citation analysis] | article | 6 |
2009 | Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science. [Full Text][Citation analysis] | article | 32 |
2000 | Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
2016 | “New Age” Decision Making in HTA: Is It Applicable in Asia? In: Briefing. [Full Text][Citation analysis] | paper | 0 |
2011 | Incorporating Multiple Criteria in HTA: Methods and Processes In: Monograph. [Full Text][Citation analysis] | book | 22 |
2010 | Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monograph. [Full Text][Citation analysis] | book | 21 |
2002 | Cost-Effectiveness Thresholds: Economic and ethical issues In: Monograph. [Full Text][Citation analysis] | book | 20 |
2004 | How Much Should We Spend on the NHS? In: Monograph. [Full Text][Citation analysis] | book | 2 |
2012 | Time to tweak the TTO. But how? In: MPRA Paper. [Full Text][Citation analysis] | paper | 1 |
2010 | Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making. [Full Text][Citation analysis] | article | 8 |
2010 | Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review In: Medical Decision Making. [Full Text][Citation analysis] | article | 10 |
2013 | Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions In: Medical Decision Making. [Full Text][Citation analysis] | article | 10 |
2016 | What Determines the Shape of an EQ-5D Index Distribution? In: Medical Decision Making. [Full Text][Citation analysis] | article | 2 |
2017 | EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 42 |
2017 | A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 4 |
2021 | Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 3 |
2021 | EQ-5D-5L Health-State Values for the Mexican Population In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 1 |
2022 | Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 1 |
2013 | The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 9 |
2013 | The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
2013 | Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2013 | Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
2013 | One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
2017 | Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2018 | Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
2019 | Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
2019 | A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 7 |
2020 | An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
2021 | What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2005 | A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
2017 | Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis] | article | 0 |
2021 | Giving a Voice to Marginalised Groups for Health Care Decision Making In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis] | article | 0 |
2010 | An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2013 | Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics. [Full Text][Citation analysis] | article | 13 |
2015 | A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
2018 | Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
2018 | 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2018 | Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 6 |
2018 | Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2018 | Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2020 | Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 10 |
2020 | International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
2022 | How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
2022 | A Comparison of PROPr and EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
2022 | Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2022 | Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
2022 | Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
2018 | Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 1 |
2019 | All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
2001 | Health care spending and economic output: Granger causality In: Applied Economics Letters. [Full Text][Citation analysis] | article | 57 |
2006 | A theoretical framework for TTO valuations of health In: Health Economics. [Full Text][Citation analysis] | article | 6 |
2007 | ‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics. [Full Text][Citation analysis] | article | 0 |
2011 | A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Health Economics. [Full Text][Citation analysis] | article | 31 |
2013 | A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO In: Health Economics. [Full Text][Citation analysis] | article | 16 |
2021 | Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia In: Health Economics. [Full Text][Citation analysis] | article | 1 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team